1-8 of 8
tyrosinase-related protein-2
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Vaccination with ΔCD40L or Flagellin Gene-Modified T Cells Activates Dendritic Cells In Vivo and Induces a Potent Anti-Tumor Immune Response

Adham S Bear, Meghan M Turnis, PhD, Xiao-Tong Song, PhD, Russell Cruz, MD, An Lu, Stephen Gottschalk, MD, Cliona M Rooney, PhD, Aaron E Foster, PhD
Journal: Blood
Blood (2011) 118 (21): 1909.
https://doi.org/10.1182/blood.V118.21.1909.1909
Published: 2011
Journal Articles

Interferon γ limits the effectiveness of melanoma peptide vaccines

Hyun-Il Cho, Young-Ran Lee, Esteban Celis
Journal: Blood
Blood (2011) 117 (1): 135–144.
https://doi.org/10.1182/blood-2010-08-298117
Published: 2011
Includes: Supplemental data
Journal Articles

Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD
Journal: Blood
Blood (2007) 110 (11): 3076.
https://doi.org/10.1182/blood.V110.11.3076.3076
Published: 2007
Journal Articles

A Vaccination Regimen Incorporating the Synergistic Combination of CpG-Containing Oligodeoxynucleotides and IL-2 Can Elicit CD8+ T Cell Responses That Effect Anti-Tumor Immunity from T Cell Repertoires Undergoing Reconstitution by Homeostatic Peripheral Expansion after BMT.

James Kochenderfer, Christopher Chien, Jessica Simpson, Ronald Gress
Journal: Blood
Blood (2005) 106 (11): 61.
https://doi.org/10.1182/blood.V106.11.61.61
Published: 2005
Journal Articles

Synergism between CpG ODN and IL-2 Leads to Massive CD8 + T Cell Responses Against a Self-Antigen and Epitope-Specific Anti-Tumor Immunity.

Jim Kochenderfer, MD, Chris Chien, BS, Ronald Gress, MD
Journal: Blood
Blood (2004) 104 (11): 3239.
https://doi.org/10.1182/blood.V104.11.3239.3239
Published: 2004
Journal Articles

DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mice Following Sub-Lethal Irradiation and Immune Reconstitution.

Adi Diab, MD, Vanessa M. Hubbard, Adam Cohen, MD, Deonka Huggins, Adam Kochman, Jose A. Guevarra, MD, Manuel Engelhorn, PhD, Jedd D. Wolchok, MD, PhD, Marcel van den Brink, MD, PhD, Alan N. Houghton, MD, Miguel-Angel Perales, MD
Journal: Blood
Blood (2004) 104 (11): 3057.
https://doi.org/10.1182/blood.V104.11.3057.3057
Published: 2004
Journal Articles

DNA Immunization Against Melanoma Antigens Enhances Tumor Immunity in Mouse Models of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Adi Diab, MD, Miguel-Angel Perales, MD, Adam Cohen, MD, Vanessa M. Hubbard, Jeff Eng, Deonka Huggins, Manuel Engelhorn, PhD, Jose A. Guevarra, MD, Onder Alpdogan, MD, Jedd D. Wolchok, MD, PhD, Adam Kochman, Alan N. Houghton, MD, Marcel van den Brink, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 304.
https://doi.org/10.1182/blood.V104.11.304.304
Published: 2004
Journal Articles

Synergy between tumor immunotherapy and antiangiogenic therapy

Smita Nair, David Boczkowski, Benjamin Moeller, Mark Dewhirst, Johannes Vieweg, Eli Gilboa
Journal: Blood
Blood (2003) 102 (3): 964–971.
https://doi.org/10.1182/blood-2002-12-3738
Published: 2003